PE20160530A1 - Metodo para tratar onicomicosis mediante hidroxipropil quitosano - Google Patents
Metodo para tratar onicomicosis mediante hidroxipropil quitosanoInfo
- Publication number
- PE20160530A1 PE20160530A1 PE2016000252A PE2016000252A PE20160530A1 PE 20160530 A1 PE20160530 A1 PE 20160530A1 PE 2016000252 A PE2016000252 A PE 2016000252A PE 2016000252 A PE2016000252 A PE 2016000252A PE 20160530 A1 PE20160530 A1 PE 20160530A1
- Authority
- PE
- Peru
- Prior art keywords
- hydroxypropyl
- onichomycosis
- chitosane
- treat
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
La presente invencion esta dirigida a un metodo para el tratamiento de onicomicosis mediante la administracion topica de una composicion que contiene hidroxipropil quitasano como el unico ingrediente activo y, en particular, mediante la administracion de una composicion topica para las unas que consiste esencialmente en: a) hidroxipropil quitosano, b) agua, c) al menos un alcanol inferior
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13183789.0A EP2845597A1 (en) | 2013-09-10 | 2013-09-10 | Hydroxypropyl chitosan for the treatment of onychomycosis |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20160530A1 true PE20160530A1 (es) | 2016-05-21 |
Family
ID=49118439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2016000252A PE20160530A1 (es) | 2013-09-10 | 2014-09-08 | Metodo para tratar onicomicosis mediante hidroxipropil quitosano |
Country Status (20)
Country | Link |
---|---|
US (1) | US20160213705A1 (es) |
EP (2) | EP2845597A1 (es) |
JP (1) | JP2016529326A (es) |
KR (1) | KR20160051751A (es) |
CN (1) | CN105579047A (es) |
AU (1) | AU2014320473A1 (es) |
CA (1) | CA2922236A1 (es) |
CL (1) | CL2016000542A1 (es) |
CR (1) | CR20160116A (es) |
EA (1) | EA201690551A1 (es) |
HK (1) | HK1223042A1 (es) |
IL (1) | IL244423A0 (es) |
MA (1) | MA38896A1 (es) |
MD (1) | MD20160039A2 (es) |
MX (1) | MX2016003122A (es) |
PE (1) | PE20160530A1 (es) |
PH (1) | PH12016500471A1 (es) |
SG (1) | SG11201601200SA (es) |
TN (1) | TN2016000054A1 (es) |
WO (1) | WO2015036369A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2704782C1 (ru) * | 2018-10-09 | 2019-10-30 | Елена Владимировна Герасимчук | Способ криогенного лечения онихомикоза |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10035991A1 (de) | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
EP1958638A1 (en) * | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans to increase nail growth rate |
-
2013
- 2013-09-10 EP EP13183789.0A patent/EP2845597A1/en not_active Withdrawn
-
2014
- 2014-09-08 KR KR1020167004415A patent/KR20160051751A/ko not_active Application Discontinuation
- 2014-09-08 JP JP2016541906A patent/JP2016529326A/ja active Pending
- 2014-09-08 CN CN201480048539.2A patent/CN105579047A/zh active Pending
- 2014-09-08 TN TN2016000054A patent/TN2016000054A1/en unknown
- 2014-09-08 AU AU2014320473A patent/AU2014320473A1/en not_active Abandoned
- 2014-09-08 CA CA2922236A patent/CA2922236A1/en not_active Abandoned
- 2014-09-08 US US14/917,298 patent/US20160213705A1/en not_active Abandoned
- 2014-09-08 EP EP14761637.9A patent/EP3043804A1/en not_active Withdrawn
- 2014-09-08 PE PE2016000252A patent/PE20160530A1/es not_active Application Discontinuation
- 2014-09-08 MX MX2016003122A patent/MX2016003122A/es unknown
- 2014-09-08 SG SG11201601200SA patent/SG11201601200SA/en unknown
- 2014-09-08 WO PCT/EP2014/069099 patent/WO2015036369A1/en active Application Filing
- 2014-09-08 MD MDA20160039A patent/MD20160039A2/ro not_active Application Discontinuation
- 2014-09-08 EA EA201690551A patent/EA201690551A1/ru unknown
- 2014-09-08 MA MA38896A patent/MA38896A1/fr unknown
-
2016
- 2016-03-03 IL IL244423A patent/IL244423A0/en unknown
- 2016-03-07 CR CR20160116A patent/CR20160116A/es unknown
- 2016-03-09 CL CL2016000542A patent/CL2016000542A1/es unknown
- 2016-03-10 PH PH12016500471A patent/PH12016500471A1/en unknown
- 2016-09-29 HK HK16111421.8A patent/HK1223042A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2922236A1 (en) | 2015-03-19 |
EP3043804A1 (en) | 2016-07-20 |
AU2014320473A1 (en) | 2016-03-24 |
JP2016529326A (ja) | 2016-09-23 |
KR20160051751A (ko) | 2016-05-11 |
EP2845597A1 (en) | 2015-03-11 |
CN105579047A (zh) | 2016-05-11 |
HK1223042A1 (zh) | 2017-07-21 |
CR20160116A (es) | 2016-06-14 |
IL244423A0 (en) | 2016-04-21 |
MX2016003122A (es) | 2016-11-14 |
CL2016000542A1 (es) | 2016-10-07 |
TN2016000054A1 (en) | 2017-07-05 |
PH12016500471A1 (en) | 2016-05-16 |
EA201690551A1 (ru) | 2016-07-29 |
US20160213705A1 (en) | 2016-07-28 |
WO2015036369A1 (en) | 2015-03-19 |
MD20160039A2 (ro) | 2016-07-31 |
MA38896A1 (fr) | 2018-03-30 |
SG11201601200SA (en) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018001375A2 (es) | Composiciones de retinoides tópicos | |
CO6821938A2 (es) | Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1 | |
CR20180232A (es) | Macrociclos peptídicos contra acinetobacter baumannii | |
NI201700135A (es) | Derivados de ciclohexano sustituido con amido | |
CU20150163A7 (es) | DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET | |
UY32502A (es) | Agentes antihelmínticos y su utilización | |
CO7131352A2 (es) | Composiciones farmacéuticas tópicas | |
CO6710926A2 (es) | Compuestos de n-heteroarilo | |
GT201400003A (es) | Una nueva composición terapéutica que contiene apomorfina como principio activo | |
BR112013017953A2 (pt) | Composição farmacêutica, formulação tópica, método, e, composição fotossensibilizadora | |
CO7141430A2 (es) | Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación | |
UY35848A (es) | Tienopirimidinas | |
BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
GT201600131A (es) | Derivados de [1,2,4] triazolo [1,5-a] pirimidina como inhibidores de proteasoma para el tratamiento de enfermedades parasitarias tales como leishmaniasis | |
CO7101244A2 (es) | Fenilimidazopirazoles sustituidos y su uso | |
GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
CO6660486A2 (es) | Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea | |
PE20180026A1 (es) | Composicion topica curativa | |
ECSP15033898A (es) | Composición antifúngica tópica para el tratamiento de onicomicosis | |
CR20160432A (es) | Inhibidores de las vías de señalización de wnt | |
PE20150755A1 (es) | Formulacion transdermica que contiene inhibidores de cox | |
BR112014024033A8 (pt) | Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes | |
BR112013021497A2 (pt) | novo uso de composições para prevenir alopecia induzida por quimioterapia e radioterapia (cria), reduzir o impacto da cria e melhorar a aparência do cabelo recrescido depois da cria | |
CL2015001502A1 (es) | Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma. | |
AR094224A1 (es) | Composicion farmaceutica en forma de una suspension oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |